AgomAb Therapeutics NV

AGMB NASDAQ Santé & Biotech Europe
10.02 $
0.15 %

Société biopharmaceutique belge développant des anticorps thérapeutiques pour traiter les maladies inflammatoires et auto-immunes.

Performance & Momentum

6 Months 33.11 %
1 Year 33.11 %
3 Years 33.11 %
5 Years 33.11 %

Similar stocks to AgomAb Therapeutics NV

Anantys Community

Be the first to share your analysis on AgomAb Therapeutics NV.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases